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Schizophrenia is a neurodevelopment disorder in which the interplay of genes and
environment contributes to disease onset and establishment. The most consistent
pathological feature in schizophrenic patients is an enlargement of the brain ventricles.
Yet, so far, no study has related this finding with dysfunction of the choroid plexus
(CP), the epithelial cell monolayer located within the brain ventricles that is responsible
for the production of most of the cerebrospinal fluid (CSF). Enlarged brain ventricles
are already present at the time of disease onset (young adulthood) and, of notice,
isolated mild ventriculomegaly detected in utero is associated with subsequent mild
neurodevelopmental abnormalities similar to those observed in children at high risk
of developing schizophrenia. Here we propose that altered CP/CSF dynamics during
neurodevelopment may be considered a risk, causative and/or participating factor for
development of schizophrenia.
Keywords: neurodevelopment, choroid plexus, schizophrenia, cerebrospinal fluid, brain ventricles,
ventriculomegaly
OVERVIEW
Schizophrenia is a disabling psychiatric disorder that affects
0.7–1% of the population worldwide. The disease has a het-
erogeneous presentation, with disorganized positive and nega-
tive symptoms that have different levels of intensity/relevance
between individuals and across time in the same individual
(MacDonald and Schulz, 2009). Despite the evidence for a genetic
component, studies have failed to identify a disease-causative
gene (Vereczkei and Mirnics, 2011). Furthermore, the lack of
disease concordance in monozygotic twins strongly supports
the participation of environmental factors in its etiopathogene-
sis (MacDonald and Schulz, 2009; Gilmore, 2010). Thus, while
accepted as a neurodevelopment disease triggered by “environ-
mental” determinants in genetic predisposed individuals, no
definitive clues have emerged on which specific (combinatory)
factors predispose for the disease (MacDonald and Schulz, 2009).
It is, however, reasonable to propose that environmental mod-
ulators such as vitamins or hormones influence the expres-
sion of normal/mutated genes, in particular periods during
(neuro)development (which in humans lasts until the second
decade of life) and/or later in life, which may contribute to disease
onset and establishment (Palha and Goodman, 2006; Addington
and Rapoport, 2011).
Here we analyze the disease and integrate neurodevelopment,
genes and environment, from a novel perspective, bringing into
play the most well-characterized and consistent pathological
feature in schizophrenia: the enlargement of the brain ventricles
(Steen et al., 2006). Whether brain ventricle enlargement is
secondary to atrophy of the surrounding brain parenchyma,
namely the cortical formation, or to an increased intracranial
pressure, due to altered dynamics of the cerebrospinal fluid
(CSF) (production, excretion), has never been considered and/or
addressed. In fact, the literature recognizes that the meaning
and the origin of the enlarged ventricles in the schizophrenic
brain is still not known (Steen et al., 2006; Vita et al., 2006).
The brain ventricles are filled with CSF, a fluid mostly produced
by the choroid plexus (CP), a monolayer row of epithelial cells
originating in the ependymal cell layer that lines the brain ven-
tricles. In the adult human brain, approximately 160 mL of CSF
fill the ventricles, subarachnoid space, and spinal cord, which
are renewed about three to four times per day, highlighting the
secretory capacity of the CP. This capacity, higher than any other
epithelia (Brown et al., 2004), may relate to the requirement of
a tight regulation to maintain brain homeostasis. By modulating
the composition of the CSF, the CP influences the delivery of
nutrients, growth factors, and other molecules to the brain; in
addition, it also contributes to the excretion of metabolites out of
the brain (Johanson et al., 2008). Furthermore, the CP is highly
irrigated and therefore able to rapidly respond to peripheral
stimuli, as we recently showed to be the case in response to
acute peripheral inflammation (Marques et al., 2009b), adding
to several studies, by our and other laboratories, demonstrating
that changes in the CP transcriptome result in altered con-
centration of specific receptors and transporters, as well as in
the altered secretion of hormones and carrier proteins into the
CSF (Emerich et al., 2005; Marques et al., 2008, 2009c). These
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alterations have been implicated in neurodegenerative disorders
such as Alzheimer’s disease and multiple sclerosis (Reboldi
et al., 2009; Vargas et al., 2010). A further interesting finding,
not extensively reported in the literature, is the relatively high
incidence of calcifications in the CP of schizophrenic patients,
which may, as well, result from altered CP metabolism (Belmonte
de Abreu, unpublished data and Bersani et al., 1999).
Here we theorize that, in the schizophrenic brain, events dur-
ing (neuro)development may interfere with the CP’s activity or
with the ability of the brain to circulate the CSF, and that this
may relate with schizophrenia etiology and pathology, includ-
ing ventricle enlargement. With this article we intend to bring
into the research field the possible role of the CP–CSF nexus in
predisposing for/modulating schizophrenia.
THE VENTRICULAR TRIAD: BRAIN VENTRICLES,
CHOROID PLEXUS, AND CEREBROSPINAL FLUID
DURING DEVELOPMENT
The CP is a structure highly conserved both phylogenetically
and ontogenetically (Johansson et al., 2008). During ontogenetic
development, the ventricular lining is constituted by proliferating
cells, which generate all types of neuroectodermal brain cells, the
ependymoglial cells among which the ependymal cells and CP
epithelial cells are the most prominent ones (Dziegielewska et al.,
2001). At this stage the CP is, relatively to the brain parenchyma,
much bigger than in adulthood. The same applies to the lateral
ventricles, whose diameter remains stable (mean 6.4 ± 1.2mm)
from 15 weeks of gestation until the term of pregnancy (Salomon
et al., 2007). In the adult, the CP is positioned within the
ventricles of the brain: one in each lateral, one in the third, and
one in the fourth ventricle. Grossly, the CP is lobulated with a
unique and continuous line of epithelial cells originating from
the ependymal line of the ventricles and it “floats” in the CSF
space within the ventricles. The apical side of the epithelial cells
faces the CSF while the basolateral side faces the blood, lying,
therefore, in the stroma side in contact with a large number
of fenestrated capillaries. Of note, at the levels of the CP the
capillaries are fenestrated, meaning that there is no blood-brain
barrier. Therefore, within the ventricles, the CP epithelial cells
constitute the barrier that separates the blood from the CSF
and brain parenchyma. In fact, early during embryogenesis,
within the first weeks of gestation, the CP already constitutes a
fundamental functional barrier (Dziegielewska et al., 2001).
Due to its localization, the CP is ideally positioned to delivery
molecules and nutrients into and out of the brain. For that, it is
well equipped with transporters and receptors, both in the api-
cal and basolateral membranes and is also a prominent source of
neuropeptides, growth factors, and cytokines in the CNS during
development and in adulthood (Bondy et al., 1990; Yamamoto
et al., 1996; Strazielle and Ghersi-Egea, 2000; Krizhanovsky and
Ben-Arie, 2006). During development the CP displays a recog-
nized paracrine function essential for cerebellum formation, with
the effects mediated through temporally regulated retinoic acid
production (Yamamoto et al., 1996, 1998). Similarly, for example,
the insulin growth factor 2, a morphogen also secreted by the CP
into the CSF, stimulates neural cortical progenitors (Lehtinen and
Walsh, 2011).
The relevance of embryonic CSF-born molecules to brain
development is even greater if we consider that apical progeni-
tors (neuroepithelial cells and radial glial progenitors) lie adjacent
to the ventricular surface and are bathed by the CSF. In fact,
the influence of the CSF content over neural progenitor cells is
not restricted to the embryo. In adult mice it was shown that
the pattern of CSF flow inside the brain ventricles influences
the pattern of subventricular zone (SVZ) neuroblasts migration
toward the olfactory bulbs; a process known to be regulated by CP
secreted proteins such as Slit 1 (Sawamoto et al., 2006). Finally, it
is of note that several proteins known to modulate neurogenesis
are induced in the CP in response to an inflammatory stimu-
lus/infection (Marques et al., 2009a,b,c). This is of interest if one
considers that inflammation/infection during embryonic devel-
opment has been associated with increased risk of schizophrenia
(Brown, 2011; Meyer, 2011). Independently from the cause of
altered neurogenesis, and in the context of the present discus-
sion, it is of interest to consider whether a faulty neurogenesis
during development may also be at the root of the morpho-
logical and/or neurological findings in the schizophrenic brain
(including ventricle enlargement), or whether faulty neurogenesis
would provide increased sensitivity to further neurodegeneration
at maturity.
A recent study in cynomolgus monkey fetuses suggested that,
during normal development, the morphological maturation of
the lateral ventricle is linked to cortical maturation. During the
fetal period the decrease in ventricular volume is accompanied
by a decrease in the volume of the germinal matrix around
lateral ventricles and an increase in the depth of the calcarine
sulcus (Fukunishi et al., 2011). A study using magnetic reso-
nance imaging (MRI) of postmortem human fetuses showed
that the reduction of the lateral ventricle volume after 23 weeks
of gestation is paralleled by a decrease in volume of the ger-
minal matrix, in contrast to the expansion of the subcortical
structures (Kinoshita et al., 2001). Alterations in the ventricular
maturation may, therefore, interfere with the proper develop-
ment of other brain regions. In accordance, a prospective study
from our group in human fetuses with isolated mild ventricu-
lomegaly and controls, showed an inverse association between
depth of the calcarine and parieto-occipital fissures (a marker
of cortical maturation) and the ventricular diameter. The depth
of these fissures was smaller in fetuses with ventriculomegaly
than in controls (Miguelote, unpublished data). Most cases with
asymmetric ventricles also displayed asymmetry of the fissures,
with the fissure depth lower in the affected side. This associ-
ation decreases at later gestational ages, which may mean that
the difference observed at early gestational ages is caused by a
delay in the cortical maturation. Abnormalities in ventricular
and cortical maturation are pertinent in light of other find-
ings observed in postmortem brain studies of schizophrenic
patients, such as the reduced dendritic spine density in pyra-
midal neurons in input layers of the prefrontal cortex, and
abnormally oriented, with signs of arrested migration, hippocam-
pal neurons (Glantz and Lewis, 2000; MacDonald and Schulz,
2009).
Altogether, enlarged lateral ventricles during developmentmay
ultimately be the result of altered CSF formation, circulation,
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and/or homeostasis. We will next briefly address developmental
ventriculomegaly.
VENTRICULOMEGALY
Ventriculomegaly, defined as an atrial diameter ≥10mm, is a fre-
quent finding on prenatal ultrasound examination (1% of the
fetuses). It can be associated with chromosomal abnormalities,
congenital infection, cerebral vascular accidents or hemorrhage,
and other fetal cerebral and extracerebral abnormalities. The pos-
sible mechanisms causing fetal ventriculomegaly are obstruction
to CSF flow, hypersecretion of CSF (rare), defective filtration of
CSF (rare), and altered development of the intracranial architec-
ture. On this, aqueductal stenosis is the most common reason of
obstruction to CSF flow and can be caused by infections, bleed-
ing, or other pathologies that cause gliosis and obliterate the
aqueduct (D’Addario et al., 2007). Sometimes a few rudimen-
tary ependymal-lined tubules are seen in place of the aqueduct
(aqueductal forking). A multifactorial pattern of inheritance is
probably the cause, but in 5% of all cases an X-linked transmis-
sion is present (D’Addario et al., 2007). The most frequent fetal
cerebral abnormalities presented in fetus with ventriculomegaly
are agenesis of the corpus callosum, agenesis, or hypoplasia of
the cerebellar vermis (Dandy–Walker malformation), spinal neu-
ral tube defect (Chiari II malformation), and cortical migrational
abnormalities. Even when the ventriculomegaly is mild (atrial
diameter between 10 and 15mm) the fetuses are still reported
to present an increased risk of abnormal or delayed neurodevel-
opment in infancy (about 11%) (Melchiorre et al., 2009). The
progression of ventricular dilatation is one of most important
prognostic factors; progression occurs in about 15% of cases,
regression in about 32% and the remaining stay stable (Kelly et al.,
2001).
Prenatal isolated mild ventriculomegaly has been suggested to
be associated with neuropsychiatric disorders, including autism,
attention deficit hyperactivity disorder, learning disabilities, and
schizophrenia by several case series (Piven et al., 1995; Gilmore
et al., 1998, 2001). Nonetheless, long-term longitudinal series are
needed and should strongly be considered, particularly in light
of the findings relating the CP/CSF with ventricle volumes in the
schizophrenic brain as we will next address.
BRAIN VENTRICLES AND THE CP/CSF NEXUS IN THE
SCHIZOPHRENIC BRAIN
Throughout the last decade, multiple systematic and separate
meta-analysis reviews of MRI studies, which report on quanti-
tative measurements of volumes of brain regions in schizophrenic
patients (in first-episodes and on longitudinal assessments; com-
pared to healthy controls), concluded that significant overall
effect sizes were consistently demonstrated for total (particu-
larly, lateral and third) ventricular volume increase (Elkis et al.,
1995; Wright et al., 2000; Steen et al., 2006; Vita et al., 2006;
Kempton et al., 2010; Olabi et al., 2011). While ventricle enlarge-
ment is the most robust pathological finding in schizophrenia
(Shenton et al., 2001), the precise moment of ventricle enlarge-
ment is not known. Nevertheless, current evidence proposes a
two-hit model, with size and shape differences already present
before illness onset (Rosa et al., 2010; Andreasen et al., 2011) and
progressively increasing during the course of illness (at an annual
rate of +0.36% for lateral ventricle volume) (Olabi et al., 2011).
Of interest, several studies report that the ventricle enlargement
is suggested to be a disease-specific event since no differences
are found in ventricular volume when non-affected siblings are
compared to control individuals, while there are marked differ-
ences between patients and relatives or the general population
(Goldman et al., 2008; Boos et al., 2011). On this, it should be
noted that, beyond schizophrenia, enlargement of the lateral ven-
tricles can be associated with other neuropsychiatric disorders,
such as bipolar disease and major depressive disorder (Kempton
et al., 2008, 2011). Still, on schizophrenia, a genetic component of
ventricular enlargement was suggested from studies in discordant
twins when compared to mentally healthy twin pairs (Brans et al.,
2008). These observations indicate that while progressive brain
volume changes seem at least partially mediated by unique envi-
ronmental factors, significant additive genetic influences should
be considered on the correlation between volume change during
development and course of schizophrenia phenotype.
An additional aspect to be considered relates to the location
in the volume changes. Three-dimensional MRI (Meduri et al.,
2010) revealed volume differences of 26%, more pronounced in
the occipital horn (41% left, 39% right), but also present in the
frontal horn (20.5% left, 23% right), main body (19% left, 21%
right), and temporal horn (−0.7% left, 13% right) (Yotsutsuji
et al., 2003). These may reflect the tension and plasticity of white
and gray matter and CSF, occurring at different levels of lat-
eral and third ventricles. Cortical CSF volume increases in the
bilateral prefrontal, temporal, and right orbital areas have been
associated with illness duration (Molina et al., 2002). These obser-
vations support that neurodegenerative events occur throughout
the course of the disease. This is particularly interesting if one
considers the current view that schizophrenia originates from
more than a single event. The hypothesis proposed here suggests
alterations in the CP/CSF nexus as a possible key element in such
succession of events.
These observations should now bring us to the reasons of the
observed ventriculomegaly. Ventricular enlargement can result
either from brain parenchyma atrophy, leading to a novel equi-
librium by filing the space with CSF; or enlarged ventricles result
from increased CSF production or/and decreased CSF excre-
tion, during specific times in development, that force the brain
parenchyma to “shrink” or to allow the ventricles to occupy a
larger space. Notably, in a naturally occurring rat model of early
onset (E18) hydrocephalus, the obstruction of natural CSF flow
results in abnormal cell proliferation and decreased number of
cells migrating (Mashayekhi et al., 2002). Furthermore, in vitro
studies demonstrated that CSF from these hydrocephalic rats
arrested cell division in the S-phase (Owen-Lynch et al., 2003). In
this perspective, increased CSF pressure may not only physically
compromise the brain parenchyma, but also possibly, through an
altered secretome, modulate neural development in such a way
that the developing brain becomes more susceptible to a second
triggering key event in disease etiology.
Among these, a possible target of environmental triggering
events in the susceptible brain is the ongoing neurogenesis in the
adult brain [first described in the 60’s by Altman (1962)]. The
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birth, survival, and differentiation of new neurons in the adult
brain have been identified in two distinct areas: the subgran-
ular zone (SGZ) of the hippocampal dentate gyrus (DG), and
the SVZ. In the SGZ, the neural precursor cells generate a large
pool of neuroblasts and immature neurons that undergo a selec-
tion process that ends in the survival and integration of a small
number of mature and functional neurons in the adjacent gran-
ular layer of the DG. In the SVZ, neural precursor cells reside in
the walls of the lateral ventricles and divide to give rise to neu-
roblasts that migrate along the narrow rostral migratory stream
(RMS) to the olfactory bulb. While several studies have sug-
gested a role of adult neurogenesis in distinct cognitive domains
(Shors et al., 2002), the functional importance of this process
remains unclear. Importantly, it is a highly regulated process by
the action of neurotransmitters, growth factors, and hormones. In
particular, stress-induced glucocorticoid secretion downregulates
adult neurogenesis in the SGZ, while antidepressant treatment
in rats increases cell proliferation in this area (Malberg et al.,
2000). These observations have led to conflicting results on the
role of hippocampal newborn neurons in depression and in the
action of antidepressant drugs (Santarelli et al., 2003; Bessa et al.,
2009). Nonetheless, the analysis of hippocampal neural stem cell
proliferation in the postmortem brains of patients with depres-
sion, bipolar disorder, and schizophrenia revealed a significant
decrease of proliferation in the DG in the schizophrenic brains
(Reif et al., 2006). Furthermore, preclinical studies in rodents have
revealed that adult neurogenesis ablation, by irradiation of the
hippocampus and SVZ, leads to behavioral deficits associated to
schizophrenia (Iwata et al., 2008). Also, chronic treatment with
antipsychotic drugs can potentiate adult neurogenesis in the hip-
pocampus and in the SVZ. Interestingly, first-generation antipsy-
chotics like haloperidol stimulate neurogenesis in the SVZ while
the effects of second-generation antipsychotics like clozapine are
mainly observed in the SGZ of the hippocampus (Newton and
Duman, 2007). By modulating the CSF composition, alterations
in the CP transcriptome in the adult may, independently from
the ventricle size, influence adult neurogenesis, again bringing the
CP/CSF nexus into the disease.
Based on this scattered but coherent evidence, we believe that
a novel provocative view on how the CP/CSF nexus relate to
enlarged brain ventricles/CP/CSF, and other features observed in
schizophrenia, may be proposed. Testing the hypothesis is cer-
tainly challenging, when considering the limitations of studies of
schizophrenia symptoms and features in animal models on one
hand and the requirement of long longitudinal human studies
on the other. In any case, we next address how to investigate this
hypothesis, both in humans and in animal models of the disease.
HOW TO TEST THE HYPOTHESIS?
ANIMAL STUDIES
The establishment of a working animal model of schizophre-
nia is a particular challenge given that no unifying model is
available (Jaaro-Peled et al., 2010; Nestler and Hyman, 2010);
however, various animal models display neurological signs of the
disease, which can be measured. In fact, for phenotype assess-
ment, it is well accepted that prepulse inhibition (PPI) deficit is
indicative of disrupted sensorimotor gating, a cognitive process
that prevents sensory overload, and the key indicator for a
schizophrenia-like phenotype in animal models of the disease
(Powell et al., 2009; Nestler and Hyman, 2010). On established
models of schizophrenia (including neurodevelopment and/or
ventriculomegaly), characterization of the CP transcriptome and
secretome could provide clear indication on potential molec-
ular pathways related to the disease. These may be of various
natures: secretory pathways that will result in altered CSF compo-
sition, ultimately influencing the brain’s interstitial fluid and neu-
ronal/glial function; transporters that may modulate the access
of specific blood-bornmolecules including nutrients, growth fac-
tors, cytokines, or metabolite excretion out of the brain, again
with impact on the CSF composition; and receptors, both in the
basolateral and apical membranes of the CP epithelial cells, which
may participate in modulation of the secretory machinery [as we
recently showed to be the case with respect to inflammation and
iron metabolism (Marques et al., 2009a,b,c)]. Next we will briefly
describe some of the models that might prove to be particularly of
interest to study from a CP/CSF nexus perspective in the context
of schizophrenia, including: four animal models induced during
pregnancy (food deprivation, stress, administration of inflam-
matory mediators, disruption of neurogenesis), one induced in
the neonatal period (excitotoxic lesions in the ventral hippocam-
pus), the disrupted-in-schizophrenia (DISC1) null mouse model
that displays ventriculomegaly, and the spontaneously hyperten-
sive rat that presents ventriculomegaly as a result of increased CSF
secretion.
The prenatal models (Meyer and Feldon, 2010) are thought
to be relevant from human epidemiological studies showing that
the risk of developing schizophrenia is higher upon prenatal
(or perinatal) insults such as maternal exposure to malnutri-
tion, stress, infection, and/or immune activation (as reviewed:
Tandon et al., 2008a,b; MacDonald and Schulz, 2009). With
respect to malnutrition/prenatal famine (the consequences of
which, in schizophrenia incidence, have been derived from epi-
demiological studies such as the “Dutch Hunger Winter” and
the “Chinese Famine,” and others, as reviewed by Brown and
Susser, 2008), the condition is replicated in animal models by
prenatal protein deprivation of pregnant rats (reviewed, Meyer
and Feldon, 2010) so to explore, in the offspring, alterations
in dopamine neurochemistry and deficits in PPI, prominent
characteristics of the disease (Toda and Abi-Dargham, 2007).
Other prenatal risk factors can also be mimicked: treatment
of pregnant rats with dexamethasone during the final week of
gestation constitutes a unifying model of stress involvement in
schizophrenia (Koenig et al., 2002), while lipopolysaccharide
(bacterial endotoxin) administration of rats at later stages of
pregnancy, evidences that environment (infection) risk factors
during pregnancy may increase the incidence of schizophrenia,
as measured by deficits in sensorimotor gating (Fortier et al.,
2007). Finally, administration of methylazoxymethanol acetate
to pregnant dams, a model that explores the disruption of neu-
rogenesis during neurodevelopment in the offspring (Talamini
et al., 1998; Moore et al., 2006), is also a consistently used pre-
natal model of schizophrenia. Altogether, these models also fulfill
the expectation of the neurodevelopmental theory of schizophre-
nia, as pointed out by Meyer and Feldon (2010). However, other
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“non-exposure” models are also relevant from a neurodevelop-
mental perspective. At the neonatal period, excitotoxic lesion(s)
in the ventral hippocampus model are used to simulate neuro-
biological aspects of schizophrenia; interestingly, after puberty
these animals present a schizophrenia-like behavioral phenotype
(Tseng et al., 2009). The spontaneous hypertensive rat, which
displays both ventriculomegaly (Ruchoux et al., 1992) and signs
of altered dopaminergic signaling (van den Buuse, 2004), could
also be an especially relevant animal model to scrutinize in
the context of the CP–CSF nexus and ventricular enlargement
in schizophrenia. Finally, from a genetic perspective, the Disc1
model of schizophrenia is of particularly interest. Mutant Disc1
mice present enlarged lateral ventricles in juveniles, and behav-
ioral aspects similar to the pathology of patients with schizophre-
nia (Pletnikov et al., 2008; Ayhan et al., 2011; Brandon and Sawa,
2011).
The Disc1 gene encodes for DISC1, a scaffold protein widely
expressed throughout the fetal and adult brain (albeit particu-
larly prominent in the human hippocampus), which contains
domains for proteins involved in neurodevelopment, cytoskele-
tal function, neurite outgrowth, and cAMP signaling (Wexler and
Geschwind, 2011). Common DISC1 polymorphisms are associ-
ated with neuropsychiatric phenotypes including altered cogni-
tion, and brain structure and function (Brandon et al., 2009;
Ayhan et al., 2011; Brandon and Sawa, 2011). How DISC1 reg-
ulates these different aspects is not well understood; however,
recent studies have greatly elucidated on possible mechanisms
and provided clues of DISC1’s plethora of actions. For exam-
ple, on neuronal development, Kang et al. (2011) have shown
that DISC1 interacts with fasciculation and elongation protein
zeta-1 (FEZ1)to synergistically regulate dendritic growth of new-
born neurons in the adult mouse hippocampus. Genetic associa-
tion studies in cohorts of schizophrenia patients further revealed
an epistatic interaction between FEZ1 and DISC1 for risk of
schizophrenia. Wang et al. (2011) explored DISC1 in synap-
tic function, reporting Nck-interacting kinase (TNIK) as a key
synaptic partner for DISC1, providing evidence that the DISC1–
TNIK interaction regulates synaptic composition and activity by
stabilizing the levels of key postsynaptic density proteins. Finally,
also recently, common DISC1 polymorphisms have been iden-
tified to disrupt Wnt/GSK3β signaling and, consequently, brain
(neuro)development (Singh et al., 2011).
While information obtained from animal data may provide
proof of concept for the proposed hypothesis, this will always be
limited given the impossibility to directly translate the observa-
tion into humans. Nonetheless, studying the CP transcriptome
in these various models will certainly bring into the equation-
specific pathways that may be common among all and offer
key-insights for human studies considerations.
HUMAN STUDIES
Addressing how the CP/CSF nexusmay be involved in the etiology
of schizophrenia will certainly be a difficult endeavor to study in
humans. It is one of the aims of this article to challenge others in
the scientific community to either revisit medical records or infor-
mation from schizophrenic patients, or to encourage the design of
longitudinal studies that may contribute to test this hypothesis.
In human studies, a feasible way to get insight on the CP’s pos-
sible involvement in schizophrenia could be by checking whether
genes that emerge from the characterization of the CP transcrip-
tome in the animal models have been linked or associated with
the disease. Of interest, aquaporins 1, 4, and 10, which are abun-
dant in the CP, are within the genetic loci mostly implicated in
schizophrenia (7p15.1, 18q11.2, 1q21.3).We have recently charac-
terized the CPmouse transcriptome in basal conditions (Marques
et al., 2011) and could next search, in the publically available
databases, whether CP genes have been identified as altered in
brains from schizophrenic patients or have been associated with
the disease. While a positive association study may be encourag-
ing, we are aware that a negative finding on the transcriptome
studies does not exclude the hypothesis, since no study to data
has specifically addressed the gene expression profile in the CP
tissue of patients. Studying the CP transcriptome from patients
would certainly be another approach. Again, and as for any other
transcriptome study in patients suffering from a chronic disease
and subjected to various and prolonged medication, a defini-
tive link between the transcriptome and the disease cannot be
fully established given the influence of the disease in itself and of
the treatment, on top of other medical conditions that may have
developed in the meantime.
A more valuable but less feasible (but not impossible!)
approach would be to follow newborns, who have been identi-
fied with mild ventricle enlargement on fetal ultrasound scan,
into adulthood, with a detailed characterization of behavior. The
lateral ventricle width is routinely assessed on second trimester
ultrasound examination. Furthermore, ventriculomegaly is a rel-
atively common finding (∼=1%) of clinical relevance as a marker
of a variety of underlying disorders (chromosomal abnormalities,
congenital infection, cerebral vascular accidents or hemorrhage,
and other fetal cerebral and extracerebral abnormalities). When
ventricle dilatation is mild (10–15mm), and there are no asso-
ciated anomalies, the risk of abnormal or delayed neurodevelop-
ment in infancy is still higher than the estimated for the general
population. The association between prenatal isolated mild ven-
triculomegaly and neuropsychiatric disorders remains, however,
to be established.
A final suggestion would be to monitor ventricular enlarge-
ment in the progeny of patients with schizophrenia, as an attempt
to identify how early ventricular enlargement is observed in indi-
viduals that ultimately develop the disease; and to follow first
episode patients on how additional ventricular enlargement may
relate with disease progression and response to treatment. It
will always be difficult to discriminate between ventricular vol-
ume findings and other genetic aspects that may predispose the
progeny of schizophrenic patients for disease development, but
this will certainly be a piece of information to add to the others
proposed this far.
CONCLUDING REMARKS
The brain barriers have only recently started to be seen as more
than mere obstacles for the passage of molecules and cells in and
out of the brain. It is now clear that they actively participate in
modulating brain homeostasis in health and in disease (Marques
et al., 2009a,b; Zlokovic, 2010). Despite the fact that the CP is
Frontiers in Cellular Neuroscience www.frontiersin.org August 2012 | Volume 6 | Article 31 | 5
Palha et al. Cerebrospinal fluid dynamics in schizophrenia
FIGURE 1 | The choroid plexus/CSF nexus in ventriculomegaly. The figure depicts schematically how various insults may influence the CP/CSF
homeostasis during development and in the adult brain, resulting in ventriculomegaly.
on the interface between the CNS and the periphery, and
thus in a privileged position to mediate interactions between
the periphery and the CNS, little attention has been devoted
to the CP in psychiatric disorders. Regarding schizophrenia
in particular, several lines of evidence point to the CP/CSF
nexus as a potential site of altered homeostasis; chiefly among
which, enlarged ventricles are the common pathological find-
ing in the schizophrenic brain, and no data is available on
whether this is simply a consequence or a causative event in
the disease. Surprisingly, both aspects, the CP privileged loca-
tion and functions, together with the enlarged ventricles find-
ings, have remained vastly unexplored in schizophrenia research.
Nonetheless, it is reasonable to expect that maternal condition
such as exposure to pathogens/infection, malnutrition, or stress,
all implicated in schizophrenia, influence: (1) the CP secre-
tory rate, as well as its secretory/homeostatic profile, ultimately
resulting in enlarged ventricles and (2) neurogenesis/cortical
migration. In summary, as depicted in Figure 1, both dur-
ing development and in the adult brain, it is reasonable to suggest
that the CP/CSF nexus may influence the onset and progression
of schizophrenia.
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